NEBIVOLOL HYDROCHLORIDE (nebivolol) by Hetero is adrenergic beta-antagonists [moa]. Approved for hypertension, to lower blood pressure, to lower blood pressure [ see clinical studies ( ) ] and 1 more indications. First approved in 2022.
Drug data last refreshed 22h ago
Adrenergic beta-Antagonists
beta-Adrenergic Blocker
Worked on NEBIVOLOL HYDROCHLORIDE at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg
Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH